Senores Pharmaceuticals
SENORES •NSE

Senores Pharmaceuticals

₹1,320.00-5.60 (0.42%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
1,306.30
Today’s high
1,344.40
52 week low
700.75
52 week high
1,599.00
Open price
1,328.80
Previous close
1,325.60
Live volume
1,41,415
Lower circuit
1,056.00
Upper circuit
1,584.00

Fundamentals

Market Cap
₹6,094Cr
ROE
12.36%
P/E Ratio(TTM)
46.58
EPS(TTM)
28.41
P/B Ratio
6.53
Dividend Yield
0.00%
Industry P/E
37.59
Book Value
202.72
Debt to Equity
0.37
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
JUN '26
₹183Cr
-5.10%
₹30.45Cr
-16.96%
050100150200
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
1Y (TTM)+25%
3Y CAGR+159%
Profit growthValue
1Y (TTM)+44%
3Y CAGR+139%

About

Senores Pharmaceuticals Limited manufactures pharmaceutical formulations and active pharmaceutical ingredients (APIs).;
CEO/MD
Swapnil Jatinbhai Shah
Founded in
2017
NSE symbol
SENORES

Shareholding pattern

Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Shareholder details

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹2,460.80
-88.00 (3.45%)
L
    H
    19,387.9228.595.75
    PfizerPFIZER
    ₹3,808.20
    +58.20 (1.55%)
    L
      H
      17,153.3423.334.08
      Natco PharmaNATCOPHARM
      ₹789.40
      -6.00 (0.75%)
      L
        H
        15,614.9713.641.49
        ₹931.90
        -0.30 (0.03%)
        L
          H
          14,850.7442.262.09
          Livesquawk •
          Senores Pharma plans INR130 crore CapEx in FY27 to expand oral solid capacity and pilot injectable plant. Near-term run rate expected at INR60-75 crore for the next year, as per Concall update.
          2026
          27
          Jul
          Quarterly Result
          Release date
          14
          May
          Annual Result
          Release date
          20
          Jan
          Quarterly Result
          Release date
          2025
          6
          Nov
          Quarterly Result
          Release date
          23
          Jul
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks